Potstock, good question. There are multiple articles which state the cost of Orphan drugs are in the hundreds of thousands per annum. I have only used 1 hundred thousand. As far as health care funds go, there is an article from thcare-economist which states that health plan seem to apply no restrictions to 70% of Orphan drug cost, have minor restrictions for 29% and don't respond to 1%.
However, above all of this are the discussions I have had with companies in this space. I am very comfortable with a 100k USD PA revenue assumption.
Ann: Notification of investor briefing webinar, page-31
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.85 |
Change
-0.110(0.85%) |
Mkt cap ! $1.598B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.53 | $6.559M | 511.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1657 | $12.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.85 | 6303 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |